{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:54:11Z","timestamp":1793930051131,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","award":["19-B-0020"],"award-info":[{"award-number":["19-B-0020"]}],"id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Use of psychotropics is relatively prevalent amongst motor vehicle drivers because mobility is also important for persons suffering from psychiatric illness. However, medication side effects may increase the likelihood of being involved in traffic crashes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study aimed to assess the association between the use of four types of medication (antipsychotics, benzodiazepines and z-hypnotics, antidepressants and stimulants of ADHD treatment) and the risk of traffic crashes, in general, and single crashes subsequently.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We conducted a case\u2013control study of data from 130,000 drivers involved in traffic crashes with personal injury and prescription data from all of Denmark during the period 1996\u20132018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For antipsychotics, we found odds ratios of 0.86 and 1.29 for traffic crashes and single crashes, respectively; for benzodiazepines and z-hypnotics, 1.29 and 2.49, respectively; for antidepressants, 1.30 and 2.25, respectively; and for stimulants of ADHD treatment, 1.62 and 1.95, respectively. All <jats:italic>p<\/jats:italic> values were below 0.001.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on our results on twofold increased risks of single crashes and moderately increased risks in persons with ADHD, it might seem tempting to ban psychotropic medication in traffic. Conversely, we accept increased risks of traffic crashes in young drivers and in the physically disabled with special aids and, to some extent, with exposure to alcohol. In the end, it is the authorities who must review the evidence and decide whether to prohibit (some types of) psychotropic medication in traffic. Finally, underlying disease and not the drug may increase the risk of being involved in a traffic crash.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-022-06146-0","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T09:02:50Z","timestamp":1650704570000},"page":"2537-2546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Use of psychotropic medication and risk of road traffic crashes: a registry-based case\u2013control study in Denmark, 1996\u20132018"],"prefix":"10.1007","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-8269","authenticated-orcid":false,"given":"Anne Vingaard","family":"Olesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja Kidholm Osmann","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Lahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmi","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"key":"6146_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpsychires.2018.02.026","volume":"101","author":"PA Aduen","year":"2018","unstructured":"Aduen PA, Kofler MJ, Sarver DE, Wells EL, Soto EF, Cox DJ (2018) ADHD, depression, and motor vehicle crashes: a prospective cohort study of continuously-monitored, real-world driving. J Psychiatr Res 101:42\u201349. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.026","journal-title":"J Psychiatr Res"},{"key":"6146_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","volume":"352","author":"F Barbone","year":"1998","unstructured":"Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331\u20131336. https:\/\/doi.org\/10.1016\/S0140-6736(98)04087-2","journal-title":"Lancet"},{"issue":"7","key":"6146_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4088\/JCP.V69N0709","volume":"69","author":"JG Bramness","year":"2008","unstructured":"Bramness JG, Skurtveit S, Neutel CI, M\u00f8rland J, Engeland A (2008) Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiatry 69(7):1099\u20131103. https:\/\/doi.org\/10.4088\/JCP.V69N0709","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"6146_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00702-012-0833-8","volume":"120","author":"A Brunnauer","year":"2013","unstructured":"Brunnauer A, Laux G (2013) The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review: 70th birthday Prof. Riederer J Neural Transm 120(1):225\u2013232. https:\/\/doi.org\/10.1007\/s00702-012-0833-8","journal-title":"Riederer J Neural Transm"},{"issue":"5","key":"6146_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/S-0043-113572","volume":"50","author":"A Brunnauer","year":"2017","unstructured":"Brunnauer A, Laux G (2017) Driving under the influence of antidepressants: a systematic review and update of the evidence of experimental and controlled clinical studies. Pharmacopsychiatry 50(5):173\u2013181. https:\/\/doi.org\/10.1055\/S-0043-113572","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"6146_CR6","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.4088\/JCP.v69n1205","volume":"69","author":"A Brunnauer","year":"2008","unstructured":"Brunnauer A, Laux G, David I, Fric M, Hermisson I, M\u00f6ller HJ (2008) The impact of Reboxetine and Mirtazapine on driving simulator performance and psychomotor function in depressed patients. J Clin Psychiatry 69(12):1880\u20131886. https:\/\/doi.org\/10.4088\/JCP.v69n1205","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"6146_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-0034-1398509","volume":"48","author":"AV Brunnauer","year":"2015","unstructured":"Brunnauer AV, Buschert MF, Distler G, Sander K, Segmiller F, Zwanzger P, Laux G (2015) Driving performance and psychomotor function in depressed patients treated with Agomelatine or Venlafaxine. Pharmacopsychiatry 48(2):65\u201371. https:\/\/doi.org\/10.1055\/s-0034-1398509","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"6146_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/13651501.2015.1089293","volume":"20","author":"A Brunnauer","year":"2016","unstructured":"Brunnauer A, Buschert V, Segmiller F, Zwick S, Bufler J, Schmauss M, Messer T, M\u00f6ller HJ, Frommberger U, Bartl H, Steinberg R, Laux G (2016) Mobility behaviour and driving status of patients with mental disorders - an exploratory study. Int J Psychiatry Clin Pract 20(1):40\u201346. https:\/\/doi.org\/10.3109\/13651501.2015.1089293","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"9","key":"6146_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/ijnp\/pyab031","volume":"24","author":"A Brunnauer","year":"2021","unstructured":"Brunnauer A, Herpich F, Zwanzger P, Laux G (2021) Driving performance under treatment of most frequently prescribed drugs for mental disorders: a systematic review of patient studies. Int J Neuropsychopharmacol 24(9):679\u2013693. https:\/\/doi.org\/10.1093\/ijnp\/pyab031","journal-title":"Int J Neuropsychopharmacol"},{"key":"6146_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1017\/S0714980816000064","volume":"35","author":"DH Cameron","year":"2016","unstructured":"Cameron DH, Rapoport MJ (2016) Antidepressants and driving in older adults: a systematic review. Can J Aging 35:7\u201314. https:\/\/doi.org\/10.1017\/S0714980816000064","journal-title":"Can J Aging"},{"key":"6146_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1365-2125.2012.04410.x","volume":"75","author":"CM Chang","year":"2013","unstructured":"Chang CM, Wu ECH, Chen CY, Wu KY, Liang HY, Chau YL, Wu CS, Lin KM, Tsai HJ (2013) Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study. Br J Clin Pharmacol 75:1125\u20131133. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04410.x","journal-title":"Br J Clin Pharmacol"},{"key":"6146_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2017.0659","volume":"74","author":"Z Chang","year":"2017","unstructured":"Chang Z, Quinn PD, Hur K, Gibbons RD, Sj\u00f6lander A, Larsson H, D\u2019Onofrio BM (2017) Association between medication use for attention-deficit\/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 74:597\u2013603. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0659","journal-title":"JAMA Psychiatry"},{"key":"6146_CR13","unstructured":"Christiansen H, Warnecke ML (2018) Risiko i trafikken 2007\u201316 [Risk in traffic 2007\u20132016]. https:\/\/backend.orbit.dtu.dk\/ws\/portalfiles\/portal\/146185353\/Risiko_i_trafikken_2007_16.pdf. Accessed 30 June 2021"},{"issue":"2","key":"6146_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/JCP.0b013e3182496dc5","volume":"32","author":"DJ Cox","year":"2012","unstructured":"Cox DJ, Davis M, Mikami AY, Singh H, Merkel RL, Burket R (2012) Long-acting methylphenidate reduces collision rates of young adult drivers with Attention-Deficit\/Hyperactivity Disorder. J Clin Psychopharmacol 32(2):225\u2013230. https:\/\/doi.org\/10.1097\/JCP.0b013e3182496dc5","journal-title":"J Clin Psychopharmacol"},{"key":"6146_CR15","unstructured":"Danish Patient Safety Authority (2017) Vejledning om helbredskrav til k\u00f8rekort [Guidance to health requirements of licensed drivers]. https:\/\/stps.dk\/da\/udgivelser\/2017\/vejledning-om-helbredskrav-til-koerekort\/~\/media\/9BE267FAC6AE4BE3ABB93FAA6E7C2347.ashx. Accessed 7 September 2021"},{"key":"6146_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.aap.2012.06.017","volume":"60","author":"R Elvik","year":"2013","unstructured":"Elvik R (2013) Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev 60:254\u2013267. https:\/\/doi.org\/10.1016\/j.aap.2012.06.017","journal-title":"Accid Anal Prev"},{"key":"6146_CR17","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2012) Driving under the influence of drugs, alcohol and medicines in Europe - findings from the DRUID project. Luxembourg. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/743\/TDXA12006ENN_402402.pdf. Accessed 19 March 2022."},{"key":"6146_CR18","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1007\/s00702-015-1465-6","volume":"124","author":"ABM Fuermaier","year":"2017","unstructured":"Fuermaier ABM, Tucha L, Evans BL, Koerts J, de Waard D, Brookhuis K, Aschenbrenner S, Thome J, Lange KW, Tucha O (2017) Driving and attention deficit hyperactivity disorder. J Neural Transm 124:S55-67. https:\/\/doi.org\/10.1007\/s00702-015-1465-6","journal-title":"J Neural Transm"},{"key":"6146_CR19","unstructured":"Hansen HL, Gr\u00f8nlykke T, Fredsted B, Bryld C, Adelhardt M, Garsdal L, Danish Health Authority (2014) Traffic and medications. https:\/\/www.sst.dk\/da\/udgivelser\/2014\/rationel-farmakoterapi-2-2014\/trafik-og-laegemidler. Accessed 7 October 2018"},{"key":"6146_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.aap.2013.06.003","volume":"59","author":"T Hels","year":"2013","unstructured":"Hels T, Lyckegaard A, Simonsen KW, Steentoft A, Bernhoft IM (2013) Risk of severe driver injury by driving with psychoactive substances. Accid Anal Prev 59:346\u2013356. https:\/\/doi.org\/10.1016\/j.aap.2013.06.003","journal-title":"Accid Anal Prev"},{"key":"6146_CR21","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1136\/injuryprev-2013-040757","volume":"21","author":"M Kruse","year":"2015","unstructured":"Kruse M (2015) Costs of traffic injuries. Inj Prev 21:e4-9. https:\/\/doi.org\/10.1136\/injuryprev-2013-040757","journal-title":"Inj Prev"},{"key":"6146_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/clpt.2011.3","volume":"89","author":"L Orriols","year":"2011","unstructured":"Orriols L, Philip P, Moore N, Castot A, Gadegbeku B, Delorme B, Mallaret M, Largarde E (2011) Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 89:595\u2013601. https:\/\/doi.org\/10.1038\/clpt.2011.3","journal-title":"Clin Pharmacol Ther"},{"key":"6146_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4088\/JCP.11m07624","volume":"73","author":"L Orriols","year":"2012","unstructured":"Orriols L, Queinec R, Philip P, Gadegbeku B, Delorme B, Moore N, Suissa S, Lagarde E (2012) Risk of injurious road traffic crash after prescription of antidepressants. J Clin Psychiatry 73:1088\u20131094. https:\/\/doi.org\/10.4088\/JCP.11m07624","journal-title":"J Clin Psychiatry"},{"key":"6146_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/bcp.13075","volume":"82","author":"L Orriols","year":"2016","unstructured":"Orriols L, Luxcey A, Contrand B, Gadegbeku B, Delorme B, Tricotel A, Moore N, Salmi LR, Lagarde E (2016) Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility study. Br J Clin Pharmacol 82:1625\u20131635. https:\/\/doi.org\/10.1111\/bcp.13075","journal-title":"Br J Clin Pharmacol"},{"key":"6146_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","volume":"7","author":"CB Pedersen","year":"2014","unstructured":"Pedersen CB, Mors O, Bertelsen A, Waltoft BL, Agerbo E, McGrath JJ, Mortensen PB, Eaton WW (2014) A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 7:573\u2013581. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.16","journal-title":"JAMA Psychiatry"},{"key":"6146_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/JGP.0b013e31820d93f9","volume":"19","author":"MJ Rapoport","year":"2011","unstructured":"Rapoport MJ, Zagorski B, Seitz D, Herrmann N, Molnar F, Redelmeier DA (2011) At-fault motor vehicle crash risk in elderly patients treated with antidepressants. Am J Geriatr Psychiatry 19:998\u20131006. https:\/\/doi.org\/10.1097\/JGP.0b013e31820d93f9","journal-title":"Am J Geriatr Psychiatry"},{"key":"6146_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2125.2011.03994.x","volume":"72","author":"S Ravera","year":"2011","unstructured":"Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LTW, (2011) Road traffic accidents and psychotropic medication use in the Netherlands: a case-control study. Br J Clin Pharmacol 72:505\u2013513. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03994.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"6146_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00702-007-0834-1","volume":"115","author":"E Sobanski","year":"2008","unstructured":"Sobanski E, Sabljic D, Alm B, Skopp G, Kettler N, Mattern R, Strohbeck-K\u00fchner P (2008) Driving-related risks and impact of Methylphenidate treatment on driving in adults with Attention-Deficit\/Hyperactivity Disorder (ADHD). J Neural Transm 115(2):347\u2013356. https:\/\/doi.org\/10.1007\/s00702-007-0834-1","journal-title":"J Neural Transm"},{"issue":"6","key":"6146_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eurpsy.2012.08.001","volume":"28","author":"E Sobanski","year":"2013","unstructured":"Sobanski E, Sabljic D, Alm B, Dittmann RW, Wehmeier PM, Skopp G, Strohbeck-K\u00fchner P (2013) Driving performance in adults with ADHD: results from a randomized, waiting list controlled trial with Atomoxetine\u201d. Eur Psychiatry 28(6):379\u2013385. https:\/\/doi.org\/10.1016\/j.eurpsy.2012.08.001","journal-title":"Eur Psychiatry"},{"key":"6146_CR30","unstructured":"StataCorp. (2019) STATA statistical software: Release 16"},{"key":"6146_CR31","unstructured":"Statistics Denmark (2021) Road traffic of Danish vehicles on Danish roads by means of transport. https:\/\/statistikbanken.dk\/statbank5a\/default.asp?w=1920. Accessed 30 June 2021"},{"key":"6146_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.aap.2013.10.003","volume":"62","author":"T Vaa","year":"2014","unstructured":"Vaa T (2014) ADHD and relative risk of accidents in road traffic: a meta-analysis. Accid Anal Prev 62:415\u2013425. https:\/\/doi.org\/10.1016\/j.aap.2013.10.003","journal-title":"Accid Anal Prev"},{"key":"6146_CR33","unstructured":"Van den Berghe W (2017) The association between road safety and socioeconomic situation (SES). An international literature review. Vias Institute - Knowledge Centre Road Safety, Brussels, Belgium. https:\/\/www.vias.be\/publications\/HetverbandtussenSESenverkeersveiligheid\/The_association_between_road_safety_and_socio-economic_situation_(SES).pdf. Accessed 19 Feb\u00a02022"},{"key":"6146_CR34","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/15389588.2014.926341","volume":"15","author":"E Vingilis","year":"2014","unstructured":"Vingilis E, Mann RE, Erickson P, Toplak M, Kolla NJ, Seeley J, Jain U (2014) Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative Canadian sample. Traffic Inj Prev 15:S1-9. https:\/\/doi.org\/10.1080\/15389588.2014.926341","journal-title":"Traffic Inj Prev"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06146-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T15:09:36Z","timestamp":1658156976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06146-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6146"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06146-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}